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Abstract
Summary Background Data—Mechanical forces play an important role in tissue
neovascularisation and are a constituent part of modern wound therapies. The mechanisms by
which Vacuum Assisted Closure (VAC) modulates wound angiogenesis are still largely unknown.
Objective—To investigate how VAC treatment affects wound hypoxia and related profiles of
angiogenic factors as well as to identify the anatomical characteristics of the resultant, newly
formed vessels.
Methods—Wound neovascularization was evaluated by morphometric analysis of CD31- stained
wound cross sections as well as by corrosion casting analysis. Wound hypoxia and mRNA
expression of HIF-1α and associated angiogenic factors were evaluated by pimonidazole
hydrochloride staining and quantitative RT-PCR, respectively. VEGF protein levels were
determined by western blot analysis.
Results—VAC-treated wounds were characterized by the formation of elongated vessels aligned
in parallel and consistent with physiologically function, compared to occlusive dressing control
wounds that showed formation of tortuous, disoriented vessels. Moreover, VAC-treated wounds
displayed a well-oxygenated wound bed, with hypoxia limited to the direct proximity of the VAC-
foam interface, where higher VEGF levels were found. By contrast, occlusive dressing control
wounds showed generalized hypoxia, with associated accumulation of HIF-1α and related
angiogenic factors.
Address for correspondence: Paolo Erba, MD Department of Plastic, Reconstructive and Aesthetic Surgery University Hospitals of
Basel and Lausanne CH-1011 Lausanne, Switzerland Tel: +41 21 314 76 51 Fax: +41 61 265 73 01 erbapaolo@hotmail.com.
Financial disclosure: Dr. Orgill is an expert witness for Akin, Gump, Strauss, Hauer & Feld, LLP that represents Kinetics Concepts,
Inc. Dr. Orgill is a principal investigator for a research grant to Brigham and Women’s Hospital funded by Kinetics Concepts, Inc.
NIH Public Access
Author Manuscript
Ann Surg. Author manuscript; available in PMC 2012 July 24.
Published in final edited form as:













Conclusions—The combination of established gradients of hypoxia and VEGF expression
along with mechanical forces exerted by VAC therapy was associated with the formation of more
physiological blood vessels compared to occlusive dressing control wounds. These morphological
changes are likely a necessary condition for better wound healing.
INTRODUCTION
Angiogenesis, the generation of new blood vessels into a tissue or organ, is controlled by a
complex regulatory system and is critical for wound and tissue repair. Alterations of this
system lead to uncontrolled angiogenesis, a condition related to tumors. Decreased ability to
form normal vessels during repair in diabetic patients leads to delayed healing 1. Among the
variety of factors and pathways involved in the control of angiogenesis, hypoxia seems to
play a pivotal role as it regulates the expression and stabilization of HIF-1α and thereby
stimulates the expression of VEGF, an important angiogenic factor 2-11 also involved in
collagen deposition and wound epithelialization 12, 13. Directly interconnected with the
HIF-1α -VEGF pathway and with hypoxia, the inflammatory microenvironment is another
important modulator of wound angiogenesis 14-16. Starting at day 2, macrophages become
the main source of growth factors and cytokines, including angiogenic factors such as
VEGF 17-20, whereby hypoxia is recognized as an important condition for the activation of
macrophages 21.
Angiogenesis is one of the most crucial processes involved in tissue repair 22 and is
considered to be an adaptive response to hypoxia. In skin wounds, the natural course of
hypoxia is characterized by an hypoxic peak around day 4 preceded by an absence of
hypoxia immediately after wounding and followed by a progressive increase of wound
oxygenation 23. Hypoxia plays a bivalent role in wound healing. In the initial phase of
wound healing, it aids in the recruitment and function of inflammatory cells 24, 25 as well as
the expression and stabilization of Hypoxia-Inducible-Factor-1 (HIF-1) 2, 26. HIF-1α
expression is regulated by oxygen dependent prolyl hydroxylases and proteosomal
degradation mechanisms, whereby an hypoxic environment leads to HIF-1α
accumulation 27. Although hypoxia is beneficial in the initial stage of wound healing,
starting in the proliferative phase, it leads to impaired proliferation and migration of
endothelial cells and fibroblasts 28, interruption of angiogenesis 29, decreased collagen
formation29, 30 as well as increased risk of infection31.
Several reports have brought strong evidence of biomechanical forces playing an important
role in tissue neovascularisation and we now assist to an increasing interest in trying to
understand how this phenomenon is regulated. Recently it was demonstrated that
mechanical forces affect neovascularisation not only through a modulatation of the gene
expression of angiogenic factors and their receptors 32-36, but also through a nonangiogenic
expansion of preexisting vessels and consequent formation of new, fully functional vascular
loops 37.
Vacuum Assisted Closure (VAC) is widely used in wound therapies and has been shown to
positively affect angiogenesis 38-41. Research suggests that the combination of a foam
interface with negative pressure leads to the application of mechanical microdeformations to
wound cells and thereby affects the expression of angiogenic factors 42. Other essential
components of this therapy are the continuous evacuation of wound fluid which leads to the
removal of inhibitory angiogenic factors such as matrix metalloproteinases (MMPs) 43, 44
and a modulation of the inflammatory microenvironment of wounds, which finally also
controls new vessel formation 44-46. The foam material interface is critical for the
application of micromechanical deformations to wound cells 47 as well as is involved in
modulating the migration of inflammatory cells in the treated wounds 46. Despite the
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widespread use of VAC therapy, little is known about the mechanisms of action at the
molecular level, and especially about of the mechanisms that regulate neovascularisation in
the treated wounds.
With the present study we aimed at identifying the anatomical characteristics of newly
formed vessels as well as to investigate VEGF expression profiles under the effect of
different treatment patterns of vacuum assisted closure therapy.
METHODS
Fifty adult male wild-type C57Bl6 db/+ mice (Jackson Laboratory, Bar Harbor, ME) were
included in the study. Mice were housed in an Association for Assessment and Accreditation
of Laboratory Animal Care certified facility under an approved experimental protocol. The
mice are heterozygous for a diabetic gene, but they express a normal wild-type wound
healing phenotype 48. The entire dorsum was clipped and depilated (Nair®, Church &
Dwight Co., Princeton, NJ) 24 hours prior to the experiment. Animals were anesthetized
with 60 mg/kg Nembutal (Pentobarbital) 15 minutes prior to surgery. After disinfecting the
dorsum with alcohol patches, a 1.0 cm2 area of skin and panniculus carnosus were removed
to create a full-thickness wound. To protect wound margins from excess
macrodeformations,49 a 0.5 cm wide Duoderm® (DuoDERM®, CGF®, ConvaTec, Squibb
& Sons, L.L.C.) frame was placed around the wound edges. Depending on the group,
wounds were covered by a Tegaderm 3M Dressing or by a Vacuum Assisted Closure
Device© (KCI Inc., San Antonio, TX) set at continuous 125mmHg negative pressure. The
VAC device did not affect ambulation, neither well being of the treated animals. At day 7 a
further group of mice was treated with cyclical negative pressure therapy alternating 2
minutes of negative 125mmHg with 2 minutes of negative 50mmHg. The analyzed
parameters were monitored at 6 hours (Control Group n= 6, VAC Continuous Group = 6), 3
days (Control Group n=6, VAC Continuous Group n=6) and 7 days (Control Group n=6,
VAC Continuous Group n=6, VAC Cyclical Group n=6). At day 7 corrosion casting
analysis of the newly built vessels was performed.
Immunohistochemistry
Analysis of wound bed vasculature, cellular proliferation and tissue hypoxia was performed
by immunohistochemistry. For hypoxic cell analysis, pimonidazole hydrochloride marker
(Hypoxyprobe™-1 Kit, NPI, Burlington, MA) was injected intraperitoneally 90 minutes
prior to harvesting. Central wound cross-sections, surrounding skin and underlying muscle
tissue were harvested, formalin fixed and embedded in paraffin. Paraffin-embedded sections
were rehydrated through a decreasing alcohol chain. Antigen retrieval of CD31 was
performed with 40 μg/ml Proteinase K (Roche Diagnostic Corp., Indianapolis, IN) solution
in 0.2M Tris-H2O for 20 minutes at 37°C. After application of blocking serum for 1 hour,
primary antibodies, namely CD31 (Pharmingen, San Jose, CA) for angiogenesis and anti-
Hypoxyprobe™-1 monoclonal antibody (NPI, Burlington, MA) for hypoxia were incubated
at 4°C overnight. Biotinylated mouse anti-rat secondary antibodies (Vector Laboratories
Inc., Burlingame, CA) for CD-31 and pimonidazole hydrochloride marker were used as
secondary antibodies. For CD31, signals were then amplified in association with Tyramide
Amplification System® (Perkinelmer, Boston, MA). Activation was performed with
NovaRED (Vector Laboratories, Burlingame, CA). Sections were then counterstained with
hematoxilin (Hematoxilin 1, Richard-Allan Scientific, Kalamazoo, MI). High power images
of stained sections were used to quantify the degree of wound bed angiogenesis. Six digital
images of CD-31 stained slides were captured for each sample, 2 in the middle and two on
each edge of the wound bed. Blood vessel density was quantified over the entire image and
expressed as the ratio of blood vessel number per high-powered field (hpf). A total of 36
microscopic fields were evaluated for each experimental group. Hypoxia was qualitatively
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assessed over the entire image. Central wound cross-sections were stained according to
routine H&E protocols.
Morphometric Analysis of Newly Formed Vessels
Comparison of CD31 stained slides of animals sacrificed at day 7 and comparison between
cyclical VAC therapy, continuous VAC therapy and Occlusive Dressing Control wounds
(n=6 per group). Microvessel densities were determined in frozen sections after anti-CD 31
staining. From each wound section, micrographs of representatitve areas were choosen and
evaluated with a Weibel grid 50.
Corrosion Casting Analysis
For spatial visualization of granulation tissue microvasculature, 4 mice of each group were
euthanized on day 7. Mice were anaesthetised with pentobarbital (0.1 ml, Narcoren, Merial,
Germany) and aorta was catheterised with an olive-tipped needle (Acufirm 1428LL;
Dreieich, Germany). After systemic heparinisation, 10ml of 2.5% glutaraldehyde in Ringer’s
saline solution and, subsequently, 40 ml of Mercox CL-2B resin (Vilene Med Co., Tokyo
Japan) diluted with 20% methylmethacrylate monomers (Merck Darmstadt, Germany) were
perfused. Mouse dorsal back was immersed in a 5% KOH solution to digest all the tissues
around the vessel casts. One week later the specimens were dehydrated, mounted on
conductive stubs and coated with gold in an SCD 040 sputter-coater (BAL-TEC AG, Leica
Microsystems). The specimens were visualised under a Philips XL30 scanning electron
microscope (Philips, Eindhoven, The Netherlands), and between 20 and 30 stereo pair
images with a 61 tilt angle were recorded per sample. Pairs of stereo images were analysed
with the image analysis program, Kontron KS 300 (Carl Zeiss Vision, Eching, Germany).
For details of reconstruction and calculations see Malkusch et al (1995).
Western Blot Analysis
While the distal part of the wounds served for immunhistochemistry, the granulation tissue
pertaining to the cranial part of wounds of animals sacrificed at day 3 and day 7 was
harvested and fresh frozen for western blot analysis of VEGF (n = 4 per group). Tissue
samples did not include the surrounding skin and underlying muscle tissue. In VAC treated
animals samples were harvested both from the wound bed and from the foam material
adjacent to the wound (n = 4 per group). The samples were loaded on 15% SDS–
polyacrylamide gel and run at 120V for 90 min. The protein was transferred to PVDF
membrane and subsequently blocked for 2 h with 10% milk in TBST (10mM Tris base pH
7.5, 150mM NaCl, 0.1% Tween-20). The membrane was then incubated in primary
polyclonal antibody against VEGF. Following three washes with TBST for 10 min each, the
membrane was placed in the secondary goat-anti-rabbit antibody (Rockland
Immunochemicals Inc., Gilbertsville, PA, USA) for 1 hour. The enhanced
chemiluminescence reaction (ECL,Amersham Biosciences, Iscataway, NJ, USA) was then
carried out according to the manufacturer’s instructions and films were developed for 30
seconds with phosphatase-conjugated secondary antibody.
Real Time RT-PCR Analysis
Real-time RT-PCR expression of hypoxia-induced factor 1α (HIF-1α; 5′-
CAAGTCAGCAACGTGGAAGGT -3′; 5′-CTGAGGTTGGTTACTGTTGGTATCA -3′;
Gene Bank ID NM_010431), vascular endothelial growth factor-A (VEGF; 5′-
CACTGGACCCTGGCTTTACTGC-3′; 5′-CGCCTTGGCTTGTCAC-3′; Gene Bank ID
M95200), vascular endothelial growth factor receptor 2 (VEGF-R2; 5′-
ACAGACCCGGCCAAACAA-3′; 5′-TTCCCCCCTGGAAATCCTC-3′; Gene Bank ID
NM_010612), platelet derived growth factor BB chain (PDGF; 5′-
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TGTTCCAGATCTCGCGGAAC-3′; 5′ GCGGCCACACCAGGAAG-3′; Gene Bank ID
AF162784) and platelet-derived growth factor receptor beta (PDGF-R; 5′-
GTGGTGAACTTCCAATGGACG-3′; 5′- GTCTGTCACTGGCCTCCACCAG-3′; Gene
Bank ID BC055311) was performed and compared over the different time points in both the
control and study group. At 6 hours, 3 days and 7 days after full thickness skin wounding,
fresh samples were taken from the cranial half of the wound bed including granulation tissue
and underlying muscle layer (n = 4 per group) and fresh frozen. RNA was extracted using
the RNeasy mini kit (Qiagen, Chatsworth, CA) and quantification performed using the
NanoDrop (NanoDrop Technologies, Wilmington, DE) method. We synthesized
complementary deoxyribonucleic acid (cDNA) using a SuperScript III First-Strand
Synthesis System for RT-PCR (Invitrogen Life Technologies, Carlsbad, CA). Total RNA
was mixed with random hexamers and dNTP and then incubated. RT buffer, MgCl2, DTT,
RNaseOUT and SuperScript III RT were added, incubated and cooled. Then, E.coli RNase
H was added and incubated. RT-PCR was performed in an ABI Prism7300 system (Applied
Biosystems, Foster City, CA) using RT2 SYBR Green / ROX qPCR (SA Biosciences,
Frederick, MD). Amplification of the cDNA was performed in triplicates and a dissociation
curve was generated utilizing fluorescence measurements with 28S ribosomal RNA (28S;
5′- TTGAAAATCCGGGGGAGAG-3′; 5′-ACATTGTTCCAACATGCCAG-3′; Gene
Bank ID X00525) as the endogenous control for normalization. 28S has been proved to be
the most reliable internal control for comparative analyses of transcription under hypoxic
conditions 51. Change in expression was considered significant when the baseline relative
quantity (RQ) minimum/maximum values did not overlap with the sample RQ values at the
95% confidence interval determination.
Wound Closure Analysis
Wounds were photographed immediately after wounding, at each dressing change and at
harvest time. Digital photographs captured at the end of the experiment were compared with
initial photographs by two independent observers blinded to the treatment mode. Wound
closure was calculated as a percentage of the original wound and measured by planimetric
analysis (Image J, NIH, Bethesda, MD).
Data Analysis
For comparison of two groups, a two-tailed T-test was used. For greater than two groups,
oneway analysis of variance (ANOVA) and ad hoc Fischer’s LSD tests was used to
determine the significant differences between treatment groups if the ANOVA was found to
be significant. All statistical analyses were performed using WinStat (R. Fitch Software,
Lehigh Valley, PA). A p-value less than 0.05 was considered statistically significant.
RESULTS
VAC treatment was associated with a reduced number of vessels presenting with a more
functional anatomical aspect (Figure 2, 3,4)
As a response to boosted expression of angiogenic factors, control wounds stained for
CD-31 presented with highly immature tortuous and densely packed vessels. In contrast,
VAC treated wounds presented with fewer, more functional looking vessels whose aspect
was comparable to those of vessels present in the adjacent non wounded skin. Morphometric
analysis of CD-31 stained slides revealed a higher amount of microvessels characterized by
fine vessels with small diameters.
Corrosion casting analysis showed how micromechanical forces applied by VAC literally
led to the sprouting of new blood vessel pillars directed towards the wound surface. We
remarked a directionalization of vessels located at wound margin towards wound center.
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These vessel at wound margin showed a shaped specific microvascular archictecture. Tufts
of densely packed vessel networks with large caliber at wound margin are building
elongations and enlargements as vessel in-growth to wound bed.
VAC treated wounds showed an overall improved wound oxygenation in presence of
hypoxic macrophages in direct proximity of the polyurethane foam (Figure 5)
Pimonidazole hydrochloride staining determined absence of hypoxia in both groups at 6h
after wounding. The granulation tissue of control wounds presented with a generalized
hypoxic peak at day 3 after wounding, while only residues of hypoxia were visible at day 7.
While in the control group hypoxia was diffusely localized in all wound layers, especially in
the granulation tissue and interstitial spaces, VAC treated wounds presented with an overall
improved oxygenation and with hypoxia limited to the area adjacent to the polyurethane
foam, where pimonidazole hydrochloride accumulated selectively into macrophages.
In VAC treated wounds Protein Levels of VEGF showed a VEGF gradient towards the
wound surface (Figure 5)
Western blot analysis of tissues harvested from the wound bed of VAC treated wounds
revealed a lower protein level of VEGF when compared to control wounds. Compared to
wound bed protein levels, VEGF was significantly increased in tissues harvested from the
wound surface (wound fluids and tissue contained in the VAC foam side adjacent to the
wound) thereby leading to a VEGF gradient between wound bed and wound surface.
VAC treated wounds presented with increased VEGF dimers (Figure 5)
We observed that VEGF dimers assessed by western blot analysis were increased in VAC
treated wounds when compared to control wounds both in cyclical and continuous therapy
patterns.
mRNA Expression of angiogenic factors was decreased in the wound bed of VAC treated
wounds (Figure 6)
While at 6h no significant difference among groups was found, starting at 3d after wounding
and progressively increasing over time, control wounds showed an increased expression of
angiogenic factors related to the HIF-1α – VEGF Pathway. Increased expression of HIF-1α
correlated with increased expression levels of VEGF-A and VEGF-R2. At day 7 expression
levels of HIF-1α in control wounds were increased of a 100 fold compared to those of
tissues harvested at 6 hours after wounding. During the course of wound healing, the
expression of angiogenic factors in tissues harvested from the VAC treated wounds was
overall reduced, showing an 18 fold increase at day 7. A comparable pattern was found in
cyclically treated wounds. Non published data regarding the expression of angiogenic
factors in the wound bed of animals sacrificed 2 hours after treatment revealed comparable
results to those of 6 hours wounds.
Negative pressure therapy leads to improved wound closure (Figure 7)
During the 7 days follow-up period, the wound area of both groups progressively decreased,
whereby the VAC treated group presented with a superior wound closure starting at day 3
and maintaining this trend over the entire observation treatment. In this short term
experiment, mean wound area reduction was mainly related to a higher wound edge
contraction in the VAC group as measured at postoperative day 7. Cyclically treated wounds
did not significantly differ from those treated by continuous VAC therapy.
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Vacuum assisted wound therapy is widely used to improve wound healing and has been
shown to increase wound angiogenesis 38-41. Mechanical microdeformations, evacuation of
inhibitory angiogenic factors (eg. MMPs) and increased expression of proangiogenic
cytokines have been hypothesized as possible mechanisms of action. A detailed analysis of
the mechanisms controlling neovascularisation in VAC treated wounds and in particular of
the molecular changes in the expression of angiogenic factors is missing and limited to the
study of the wound secretions collected by VAC devices. While the VAC foam itself seems
to affect angiogenesis 47, the specific properties of the foam material including mean pore
size, surface tension and surface chemistry have not been addressed by our study and would
need to be elucidated in the future in order to better understand the biologic mechanisms of
VAC induced angiogenesis.
Both morphometrical studies of CD-31 stained wound cross sections as well as corrosion
casting analysis of newly formed vessels demonstrated thatVAC treatment had a regulatory
effect on wound angiogenesis. Corrosion casting showed a better hierarchisation of the
vascularity coming closer to the normal subcutaneous vessel architecture and distribution
patterns. Previous studies of the tumour microvascular architecture have shown that the
vascular architecture determines the nutritive blood flow 52. From this it may be concluded
that a normalized vascular architecture implies a better functionality in wound healing. As a
possible consequence of a generalized wound hypoxia with consequent excessive expression
of angiogenic factors as well as an absence of a VEGF gradient, occlusive dressing control
wounds were instead characterized by the uncontrolled formation of tortuous, non
directionalized and immature vessels. This chaotic vessel arrangement probably reflects the
impaired blood flow in this region.
A recent study found higher VEGF protein levels in VAC secretions in a series of traumatic
human wounds and localized VEGF in the nearest proximity of the vacuum polyurethane
foam in proximity of macrophages 42. However, Epigard was used as a control so additional
work will need to be done to better define the effect of the interface material and cellular
response 46, 53. The different size and location of the analyzed wounds, difficulty in
standardizing the time of tissue harvest, unknown patient’s co-morbidities are other issues
that make a comparison of highly sensitive chemokine levels difficult. In another clinical
study, Grimm et al. found a significant reduction of HIF-1α after VAC treatment of radiated
skin wounds 41. Although the study had some short-comings including a limited number of
analyzed patients, unknown co-morbidities and the irradiated condition of the analyzed
wounds, it highlighted a possible relationship between VAC treatment and the HIF-1α
pathway in wounds and indirectly with the oxygenation of wounds. In effect oxygen
regulates both the expression of HIF-1α as well as its degradation. Oxygen inhibits Factor
Inhibiting HIF (FIH) and thereby reduces the transcriptional activity of HIF-1α as well as is
substrate of proxyl-4 hydroxylase, an enzyme which leads to hydroxylation and rapid
degradation of HIF-1α 27. In our experiments a generalized hypoxia occurring in control
wounds induced a high expression of HIF-1α and related angiogenic factors, while these
were decreased in well oxygenated VAC treated wounds. In our study hypoxia was
measured by pimonidazole hydrochloride staining, a marker that identifies tissue areas with
PO2 ranging from 0 to 10mmHg. This is a well validated method which proved to be more
accurate than wound oxygenation measurements made by conventional PO2 sensors since
these have a limited depth of reading and are strongly influenced by the arterial PO2 levels
and vasoconstriction 23, 54. Our experiments showed that VAC treatment was associated
with an overall improved wound oxygenation whereby at both days 3 and 7 wound
macrophages located in close proximity to the polyurethane sponge strongly co-localized
with pimonidazole staining (Figure 5). We hypothesize that the established hypoxic gradient
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and activated hypoxic macrophages were responsible for the formation of a VEGF gradient
with high VEGF protein levels in tissues harvested from the foam-wound interface and
lower levels in tissues harvested from the wound bed. That oxygen gradients are important
for angiogenesis and wound healing is not new and our findings confirm the observations
made by Knighton et al. in 1981 55. Moreover also VEGF gradients are known to be very
important for an effective angiogenesis and directional vessel outgrowth towards higher
VEGF concentrations 56, 57. We also observed a stabilization of VEGF dimers in VAC
treated wounds. This process could be mediated by mechanical forces and could be involved
in the modulation of neovascularization, as VEGF dimers are known to present with a
stronger VEGF receptor affinity and to thereby be able to achieve superior angiogenesis
compared to VEGF monomers 58, 59. Petersen et al. identified that in tendon fibroblasts
mechanical forces induce the expression of selected VEGF isoforms 60. Different patterns
and forms of applied mechanical forces could therefore influence angiogenesis through the
formation of VEGF forms with different biological function. Although the establishment of
a VEGF gradient and the stabilization of VEGF dimers may play an important role in VAC
induced angiogenesis, highly directionalized vessel growth demonstrated by corrosion
casting images suggests that a direct mechanical action exerted by the combination of a
polyurethane foam interface and negative pressure forces might also play an important role
in the expansion and sprouting of new vessels under VAC therapies as suggested by Kilarski
et al.37. Finally, the application of cyclical negative pressure therapy was associated with
hierachically built microvascular archictecture. The elongation of preexisting vessels as well
intussusceptions enable an improvement of oxygen and nutrient delivery in the granulation
tissue. VAC treatment accelarates wound healing not only by a hypoxia and VEGF driven
directionalized in-growth of new vessels in the wound bed, but also by a micromechanical
forces mediated activation of endothelial cell proliferation.
CONCLUSION
In subatmospheric pressure wound therapies, more importantly than a quantitatively high
mRNA expression of angiogenic factors, the establishment of a gradient in hypoxia and
VEGF, the stabilization of VEGF dimers as well as the direct exertion of mechanical forces
on wound cells leads to a directionalized sprouting of mature and functional vessels, a
necessary condition necessary for achieving improved wound healing.
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Diagram of the VAC mouse model used in the current study. The VAC device did not affect
ambulation, neither well being of the treated animals.
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Morphometric analysis of CD31 stained wound cross sections. VAC treatment is associated
with the formation of small endothelial vessels and higher vessel density, whereby occlusive
dressing control wounds are associated with large dilatated vessels.
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Corrosion casting analysis of control wounds. A. Change of normal arborized vasculature
towards a chaotic bloated, densely packed, tufts of vessels. B. Dilated vessel formations,
abnormal tortousity of vessels, wide alterations of vessel diameters. C. Densely packed
vessel formations, tumor-like vasculature, deregulation of normal vessel arborization, blind-
ending dilated occluded vessels.
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Corrosion casting analysis of VAC treated wounds. A. Hypervascularized wound margin,
vessel wall. B. Directionalization of vessels: from small vessels branches to tortous low
densely packed vessel formations that pursuit the wound centre. C. Arborized vessel
branches with vessel hierarchy, small vessel diameter in clearly defined vessel network,
directionalized.
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Pimonidazole hydrochloride staining of wound cross sections of animals sacrificed at Day 3
after wounding shows control wounds (C) presenting with a diffuse hypoxia of the
granulation tissue and interstitial spaces. VAC treated wounds (A and B) instead present
with a superior oxygenation of the wound bed, with few hypoxic macrophages (B) located at
the VAC-Foam interface. This Hypoxic gradient is associated with the formation of a VEGF
gradient as assessed by western blot analysis (D). VEGF protein levels are higher at the
VAC-Foam interface if compared to the wound bed. VEGF dimers are increased in the
wound bed of VAC treated wounds.
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mRNA profile of HIF-1α and related angiogenic factors and receptors during the time
course of wound healing as assessed by quantitative RT-PCR in tissues harvested from the
wound bed. In both groups mRNA expression of HIF-1α, VEGF-A, PDGF-BB and VEGF-
R2 showed a progressive increase over the observation time, whereby control wounds were
associated with a 15 fold increased expression of HIF-1α and 5 fold increased expression of
VEGF-A.
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The formation of a directionalized outgrowth of more functional vessels was associated with
improved wound closure in VAC treated wounds.
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